BioCrine is a Swedish biotechnology company developing drug candidates based on endogenous hormones and signaling molecules. The research focuses on diseases where current treatment options are limited or insufficient, with the aim of developing treatments with good efficacy and favorable safety profile. The strategy is based on exploiting natural biological mechanisms to develop new therapies with clinical relevance.
Shop in BioCrine
BioCrine is in a development phase focusing on preclinical and clinical validation and preparation for future partnerships. The company creates value through research-driven innovation, licensing in later stages of development and potentially broad therapeutic applications. With a long-term perspective and focus on indications with significant unmet medical need, BioCrine has the opportunity to take a relevant position in drug development.
Read more about BioCrineDiscover other companies similar to BioCrine
We broker deals in both innovative startups and established corporations. So far, we've completed transactions in more than 130 companies – and we actively track and have insight into over 1,000 companies. Our broad investor network means new opportunities are always on our radar.
